IFITM3 and colonic neoplasm: In 2020, Zhu et al. [38] reported that miR-152-3p inhibition or overexpression of KLF4 could reduce the expression of Ifitm3 in colon cancer cells, weakening the ability of the cancer cells to proliferate.